Last reviewed · How we verify
amodiaquine with artesunate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
amodiaquine with artesunate (amodiaquine with artesunate) — Centers for Disease Control and Prevention.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| amodiaquine with artesunate TARGET | amodiaquine with artesunate | Centers for Disease Control and Prevention | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- amodiaquine with artesunate CI watch — RSS
- amodiaquine with artesunate CI watch — Atom
- amodiaquine with artesunate CI watch — JSON
- amodiaquine with artesunate alone — RSS
Cite this brief
Drug Landscape (2026). amodiaquine with artesunate — Competitive Intelligence Brief. https://druglandscape.com/ci/amodiaquine-with-artesunate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab